SC 13G: Olema Pharmaceuticals, Inc.
Ticker: OLMA · Form: SC 13G · Filed: Dec 11, 2024 · CIK: 1750284
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Olema Pharmaceuticals, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 1,696 words · 7 min read · ~6 pages · Grade level 10.1 · Accepted 2024-12-11 16:30:15
Key Financial Figures
- $0.0001 — INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class
Filing Documents
- d904837dsc13g.htm (SC 13G) — 51KB
- 0001193125-24-275608.txt ( ) — 52KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information in this statement is true, complete and correct. Dated: December 11, 2024 Bain Capital Life Sciences Opportunities IV, L.P. By: Bain Capital Life Sciences Opportunities IV GP, LLC, its general partner By: Bain Capital Life Sciences Fund IV, L.P., its sole member By: Bain Capital Life Sciences IV General Partner, LLC, its general partner By: Bain Capital Life Sciences Investors, LLC, its manager By: /s/ Andrew Hack Name: Andrew Hack Title: Partner